Serum trimethylamine-N-oxide is associated with incident type 2 diabetes in middle-aged and older adults: a prospective cohort study.
Serum trimethylamine-N-oxide is associated with incident type 2 diabetes in middle-aged and older adults: a prospective cohort study.
复制标题
DOI:
10.1186/s12967-022-03581-7
复制
发表时间:
2022-08-18
影响因子:
7.4
通讯作者:
Zhu, Hui-lian
中科院分区:
文献类型:
--
作者:
Li, Shu-yi;Chen, Si;Lu, Xiao-ting;Fang, Ai-ping;Chen, Yu-ming;Huang, Rong-zhu;Lin, Xin-lei;Huang, Zi-hui;Ma, Jing-fei;Huang, Bi-xia;Zhu, Hui-lian
The role of trimethylamine-N-oxide (TMAO) in the development of diabetes remains controversial, and prospective data are few. We aimed to investigate the association between serum TMAO and incident type 2 diabetes in middle-aged and older adults. This study was based on the Guangzhou Nutrition and Health Study (GNHS), a community-based prospective cohort study in China. A total of 2088 diabetes-free participants aged 40–75 years were included from 2008 to 2010. Incident type 2 diabetes was ascertained during follow-up visits. Baseline serum TMAO was measured by high-performance liquid chromatography with online electrospray ionization tandem mass spectrometry. Hazard ratios (HRs) and 95% confidence intervals (95% CIs) for diabetes across tertiles of serum TMAO were calculated using Cox proportional hazard models. Prospective associations of serum TMAO with changes in glycemic traits (fasting glucose, HbA1c, insulin, HOMA-IR) over time were estimated using linear mixed-effects models (LMEMs). We ascertained 254 incident type 2 diabetes cases during a median follow-up of 8.9 years. The median (interquartile range) of serum TMAO was 1.54 (0.86–2.91) μmol/L. From the first to the third tertile of serum TMAO, the multivariable-adjusted HRs for diabetes were 1.00 (reference), 1.17 (95% CI: 0.84–1.61), and 1.42 (95% CI: 1.03–1.96) (P-trend = 0.031). LMEMs showed that the estimated yearly change in fasting glucose was 0.011 (0.001–0.022) mmol/L/y in the highest tertile of serum TMAO, compared with the lowest tertile (P-interaction = 0.044). Serum TMAO was not associated with longitudinal changes in HbA1c, insulin or HOMA-IR. Our findings suggested that higher serum TMAO was associated with a higher risk of type 2 diabetes and an increase in fasting glucose among middle-aged and older Chinese adults. Trial registration: NCT03179657. https://clinicaltrials.gov/ct2/show/NCT03179657?term=NCT03179657&draw=2&rank=1 The online version contains supplementary material available at 10.1186/s12967-022-03581-7.
登录
查看更多内容
影响因子:
5.8
作者:
Fiore, Daniela;Gianfrilli, Daniele;Isidori, Andrea M.
通讯作者:
Isidori, Andrea M.
影响因子:
7.1
作者:
Papandreou, Christopher;Bullo, Monica;Salas-Salvado, Jordi
通讯作者:
Salas-Salvado, Jordi
DOI:
10.1053/j.ajkd.2013.12.006
发表时间:
2014-05
期刊:
American journal of kidney diseases : the official journal of the National Kidney Foundation
影响因子:
--
作者:
Levey AS;Inker LA;Coresh J
通讯作者:
Coresh J
影响因子:
8.2
作者:
MATTHEWS, DR;HOSKER, JP;TURNER, RC
通讯作者:
TURNER, RC
影响因子:
4.6
作者:
Gruppen EG;Garcia E;Connelly MA;Jeyarajah EJ;Otvos JD;Bakker SJL;Dullaart RPF
通讯作者:
Dullaart RPF